重编程癌症中的葡萄糖代谢：能否将其用于癌症治疗？
Reprogramming glucose metabolism in cancer: can it be exploited for cancer therapy?
作者信息
Hay Nissim
机构信息
Department of Biochemistry and Molecular Genetics, University of Illinois at Chicago, Chicago, Illinois 60607 and Research and Development Section, Jesse Brown VA Medical Center, Chicago, Illinois 60612, USA.
出版信息
Nat Rev Cancer. 2016 Oct;16(10):635-49. doi: 10.1038/nrc.2016.77. Epub 2016 Sep 16.
Abstract
In recent years there has been a growing interest among cancer biologists in cancer metabolism. This Review summarizes past and recent advances in our understanding of the reprogramming of glucose metabolism in cancer cells, which is mediated by oncogenic drivers and by the undifferentiated character of cancer cells. The reprogrammed glucose metabolism in cancer cells is required to fulfil anabolic demands. This Review discusses the possibility of exploiting the reprogrammed glucose metabolism for therapeutic approaches that selectively target cancer cells.
摘要
近年来，癌症生物学家对癌症代谢的兴趣日益浓厚。本综述总结了我们在理解癌细胞中葡萄糖代谢重编程方面的过去和近期进展，这种重编程由致癌驱动因素和癌细胞的未分化特征介导。癌细胞中重编程的葡萄糖代谢是满足合成代谢需求所必需的。本综述讨论了利用重编程的葡萄糖代谢开发选择性靶向癌细胞的治疗方法的可能性。
相似文献
1
Reprogramming glucose metabolism in cancer: can it be exploited for cancer therapy?
Nat Rev Cancer. 2016 Oct;16(10):635-49. doi: 10.1038/nrc.2016.77. Epub 2016 Sep 16.
2
The roles of glucose metabolic reprogramming in chemo- and radio-resistance.
J Exp Clin Cancer Res. 2019 May 23;38(1):218. doi: 10.1186/s13046-019-1214-z.
3
Targeting glucose metabolism: an emerging concept for anticancer therapy.
Am J Clin Oncol. 2011 Dec;34(6):628-35. doi: 10.1097/COC.0b013e3181e84dec.
4
Fundamentals of cancer metabolism.
Sci Adv. 2016 May 27;2(5):e1600200. doi: 10.1126/sciadv.1600200. eCollection 2016 May.
5
Therapeutic targeting of Myc-reprogrammed cancer cell metabolism.
Cold Spring Harb Symp Quant Biol. 2011;76:369-74. doi: 10.1101/sqb.2011.76.011296. Epub 2011 Sep 29.
6
Catabolic metabolism during cancer EMT.
Arch Pharm Res. 2015 Mar;38(3):313-20. doi: 10.1007/s12272-015-0567-x. Epub 2015 Jan 30.
7
The Role of Glucose and Lipid Metabolism in Growth and Survival of Cancer Cells.
Recent Results Cancer Res. 2016;207:1-22. doi: 10.1007/978-3-319-42118-6_1.
8
Mevalonate metabolism in cancer.
Cancer Lett. 2015 Jan 28;356(2 Pt A):192-6. doi: 10.1016/j.canlet.2014.01.013. Epub 2014 Jan 24.
9
Metabolism and cancer: an up-to-date review of a mutual connection.
Asian Pac J Cancer Prev. 2010;11(6):1437-44.
10
Metabolic reprogramming in cancer: unraveling the role of glutamine in tumorigenesis.
Semin Cell Dev Biol. 2012 Jun;23(4):362-9. doi: 10.1016/j.semcdb.2012.02.002. Epub 2012 Feb 11.
引用本文的文献
1
Therapeutic Strategies Targeting Aerobic Glycolysis in Cancer and Dynamic Monitoring of Associated Metabolites.
Cells. 2025 Aug 19;14(16):1288. doi: 10.3390/cells14161288.
2
Peroxisomal lipid metabolism inhibits Pimozide-induced cancer cell death by regulating ATP homeostasis.
Oncogenesis. 2025 Aug 21;14(1):31. doi: 10.1038/s41389-025-00575-0.
3
Uridine as a hub in cancer metabolism and RNA biology.
Exp Mol Med. 2025 Aug 14. doi: 10.1038/s12276-025-01402-7.
4
Reprogramming White Fat Cells for Adipose Manipulation Transplantation (AMT) Therapy.
Bio Protoc. 2025 Aug 5;15(15):e5405. doi: 10.21769/BioProtoc.5405.
5
The Role of Uridine in Health and Disease.
J Inflamm Res. 2025 Jul 29;18:10163-10179. doi: 10.2147/JIR.S506308. eCollection 2025.
6
The Multifaceted Role of VIRMA, a Core Component of the Methyltransferase Complex, in Cancer and Cancer Therapy.
Biomolecules. 2025 Jun 22;15(7):912. doi: 10.3390/biom15070912.
7
Aldolase A accelerates hepatocarcinogenesis by refactoring c-Jun transcription.
J Pharm Anal. 2025 Jul;15(7):101169. doi: 10.1016/j.jpha.2024.101169. Epub 2024 Dec 16.
8
Wheels turning: CHO cell modeling moves into a digital biomanufacturing era: Subtitle: CHO Metabolic Modeling.
Comput Struct Biotechnol J. 2025 Jun 23;27:2796-2813. doi: 10.1016/j.csbj.2025.06.035. eCollection 2025.
9
Ferroptosis in cancer: revealing the multifaceted functions of mitochondria.
Cell Mol Life Sci. 2025 Jul 17;82(1):277. doi: 10.1007/s00018-025-05812-8.
10
What's on the menu?: metabolic constraints in the pancreatic tumor microenvironment.
J Clin Invest. 2025 Jul 15;135(14). doi: 10.1172/JCI191940.
本文引用的文献
1
A PHGDH inhibitor reveals coordination of serine synthesis and one-carbon unit fate.
Nat Chem Biol. 2016 Jun;12(6):452-8. doi: 10.1038/nchembio.2070. Epub 2016 Apr 25.
2
PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations.
Sci Transl Med. 2016 Mar 2;8(328):328rv4. doi: 10.1126/scitranslmed.aad7118.
3
Identification of a small molecule inhibitor of 3-phosphoglycerate dehydrogenase to target serine biosynthesis in cancers.
Proc Natl Acad Sci U S A. 2016 Feb 16;113(7):1778-83. doi: 10.1073/pnas.1521548113. Epub 2016 Feb 1.
4
Phosphoinositide 3-Kinase Regulates Glycolysis through Mobilization of Aldolase from the Actin Cytoskeleton.
Cell. 2016 Jan 28;164(3):433-46. doi: 10.1016/j.cell.2015.12.042.
5
Vitamin C selectively kills KRAS and BRAF mutant colorectal cancer cells by targeting GAPDH.
Science. 2015 Dec 11;350(6266):1391-6. doi: 10.1126/science.aaa5004. Epub 2015 Nov 5.
6
NRF2 regulates serine biosynthesis in non-small cell lung cancer.
Nat Genet. 2015 Dec;47(12):1475-81. doi: 10.1038/ng.3421. Epub 2015 Oct 19.
7
PEPCK Coordinates the Regulation of Central Carbon Metabolism to Promote Cancer Cell Growth.
Mol Cell. 2015 Nov 19;60(4):571-83. doi: 10.1016/j.molcel.2015.09.025. Epub 2015 Oct 17.
8
Mitochondrial Phosphoenolpyruvate Carboxykinase Regulates Metabolic Adaptation and Enables Glucose-Independent Tumor Growth.
Mol Cell. 2015 Oct 15;60(2):195-207. doi: 10.1016/j.molcel.2015.08.013.
9
Oxidative stress inhibits distant metastasis by human melanoma cells.
Nature. 2015 Nov 12;527(7577):186-91. doi: 10.1038/nature15726. Epub 2015 Oct 14.
10
MYC, Metabolism, and Cancer.
Cancer Discov. 2015 Oct;5(10):1024-39. doi: 10.1158/2159-8290.CD-15-0507. Epub 2015 Sep 17.
Zotero 插件